Your gateway to a free society
Article

Continuing Jobless Claims Tumble To 2-Year Lows

Continuing Jobless Claims Tumble To 2-Year Lows The number of Americans filing for jobless benefits for the first time rose from 203k to 219k last week (higher than the expected 210k), but still hovering within the low-low range of the last four years... Source: Bloomberg New Jersey and Oregon saw the largest WoW rise in initial claims while Texas and New York saw the biggest decline... But, while initial claims rose, continuing jobless claims tumbled to the lowest level since May 2024... Source: Bloomberg Soft survey data continues to signal a stressed labor market, while...
Back

aboutLiberty Portal

Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
May 13, 2026 / Ted Galen Carpenter
Payback: Russia Uses Iran as a Proxy Against the United States
Washington and Moscow both enthusiastically celebrated the victory of the Allied “Grand Alliance” over the fascist powers at the end of World War II.  Since then, however, the two capitals have typically been on opposite sides of numerous nasty geostrategic struggles around the world.  They also have relished opportunities to work with foreign countries and […]
Read more
Mar 18, 2026 /
Israel Strikes World’s Largest Natural Gas Field in Iran
Israel bombed facilities at the South Pars natural gas field in Iran. The world’s largest natural gas field is under the Persian Gulf and is split between Iran and Qatar. On Wednesday, strikes hit facilities in Iran’s Bushehr province tied to the gas field. Following the attack, Israeli officials told Axios that the operation was conducted in coordination and […]
Read more
Aug 5, 2026 / Tyler Durden
"Momentum Continues": Lilly Jumps After Raising Revenue Outlook On Surging GLP-1 Demand
"Momentum Continues": Lilly Jumps After Raising Revenue Outlook On Surging GLP-1 Demand Shares of Eli Lilly & Co. are rising in premarket trading after the pharmaceutical giant raised its full-year revenue forecast following a 48% jump in second-quarter sales, fueled by accelerating demand for the diabetes drug Mounjaro and the obesity treatment Zepbound. Lilly's second-quarter results topped Wall Street expectations: Adjusted earnings rose to $8.38 a share from $6.31 a year earlier. Revenue surged 48% to $22.97 billion, beating the $20.59 billion Bloomberg Consensus estimate. Mounjaro generated $9.94 billion in sales, exceeding...
Read more

support

If you like what we do and want to support us, then you are a fine humanitarian. Click the link below to find out more.

Support the liberty movement